Herr H - Search Results

1

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.

Bajorin DF, McCaffrey JA, Hilton S, Mazumdar M, Kelly WK, Scher HI, Spicer J, Herr H, Higgins G. Bajorin DF, et al. Among authors: herr h. J Clin Oncol. 1998 Aug;16(8):2722-7. doi: 10.1200/JCO.1998.16.8.2722. J Clin Oncol. 1998. PMID: 9704723 Clinical Trial.

2

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

Dalbagni G, Russo P, Sheinfeld J, Mazumdar M, Tong W, Rabbani F, Donat MS, Herr HW, Sogani P, dePalma D, Bajorin D. Dalbagni G, et al. J Clin Oncol. 2002 Aug 1;20(15):3193-8. doi: 10.1200/JCO.2002.02.066. J Clin Oncol. 2002. PMID: 12149290 Clinical Trial.

3

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

Dalbagni G, Russo P, Bochner B, Ben-Porat L, Sheinfeld J, Sogani P, Donat MS, Herr HW, Bajorin D. Dalbagni G, et al. J Clin Oncol. 2006 Jun 20;24(18):2729-34. doi: 10.1200/JCO.2005.05.2720. J Clin Oncol. 2006. PMID: 16782913 Clinical Trial.

4

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Galsky MD, et al. Among authors: herr hw. Urology. 2007 Feb;69(2):255-9. doi: 10.1016/j.urology.2006.10.029. Urology. 2007. PMID: 17320659 Clinical Trial.

5

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

Iyer G, Balar AV, Milowsky MI, Bochner BH, Dalbagni G, Donat SM, Herr HW, Huang WC, Taneja SS, Woods M, Ostrovnaya I, Al-Ahmadie H, Arcila ME, Riches JC, Meier A, Bourque C, Shady M, Won H, Rose TL, Kim WY, Kania BE, Boyd ME, Cipolla CK, Regazzi AM, Delbeau D, McCoy AS, Vargas HA, Berger MF, Solit DB, Rosenberg JE, Bajorin DF. Iyer G, et al. Among authors: herr hw. J Clin Oncol. 2018 Jul 1;36(19):1949-1956. doi: 10.1200/JCO.2017.75.0158. Epub 2018 May 9. J Clin Oncol. 2018. PMID: 29742009 Free PMC article. Clinical Trial.

6

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al. Motzer RJ, et al. Among authors: herr h. Cancer. 1990 Dec 15;66(12):2476-81. doi: 10.1002/1097-0142(19901215)66:12<2476::aid-cncr2820661206>3.0.co;2-d. Cancer. 1990. PMID: 2174300 Clinical Trial.

7

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.

Motzer RJ, Sheinfeld J, Mazumdar M, Bajorin DF, Bosl GJ, Herr H, Lyn P, Vlamis V. Motzer RJ, et al. Among authors: herr h. J Clin Oncol. 1995 Nov;13(11):2700-4. doi: 10.1200/JCO.1995.13.11.2700. J Clin Oncol. 1995. PMID: 7595727 Clinical Trial.

8

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.

Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P, et al. Bajorin DF, et al. Among authors: herr h. J Clin Oncol. 1993 Apr;11(4):598-606. doi: 10.1200/JCO.1993.11.4.598. J Clin Oncol. 1993. PMID: 8386751 Clinical Trial.

9

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.

Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, Bajorin DF, Bosl GJ, Mencel P, Motzer RJ. Puc HS, et al. Among authors: herr h. J Clin Oncol. 1996 Feb;14(2):454-60. doi: 10.1200/JCO.1996.14.2.454. J Clin Oncol. 1996. PMID: 8636757

10

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.

Dodd PM, McCaffrey JA, Mazumdar M, Scher H, Vlamis V, Higgins G, Herr H, Bajorin DF. Dodd PM, et al. Among authors: herr h. Cancer. 1999 Mar 1;85(5):1145-50. doi: 10.1002/(sici)1097-0142(19990301)85:5<1145::aid-cncr19>3.0.co;2-g. Cancer. 1999. PMID: 10091800 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

818 results

Search Page